BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 31322649)

  • 1. Genetic Risk Scores for Diabetes Diagnosis and Precision Medicine.
    Udler MS; McCarthy MI; Florez JC; Mahajan A
    Endocr Rev; 2019 Dec; 40(6):1500-1520. PubMed ID: 31322649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Revisiting the Polygenic Additive Liability Model through the Example of Diabetes Mellitus.
    Génin E; Clerget-Darpoux F
    Hum Hered; 2015; 80(4):171-7. PubMed ID: 27576757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic Review of Polygenic Risk Scores for Type 1 and Type 2 Diabetes.
    Padilla-Martínez F; Collin F; Kwasniewski M; Kretowski A
    Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32131491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Precision medicine in diabetes.
    Kalra S; Chaudhary S
    J Pak Med Assoc; 2019 Sep; 69(9):1394-1395. PubMed ID: 31511734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Genetic and/or clinical scores to anticipate the onset of diabetes].
    Waeber G; Mooser V; Vollenweider P
    Rev Med Suisse; 2009 Oct; 5(223):2136-8, 2140-1. PubMed ID: 19968025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential use of clinical polygenic risk scores in psychiatry - ethical implications and communicating high polygenic risk.
    Palk AC; Dalvie S; de Vries J; Martin AR; Stein DJ
    Philos Ethics Humanit Med; 2019 Feb; 14(1):4. PubMed ID: 30813945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The personal and clinical utility of polygenic risk scores.
    Torkamani A; Wineinger NE; Topol EJ
    Nat Rev Genet; 2018 Sep; 19(9):581-590. PubMed ID: 29789686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Second international consensus report on gaps and opportunities for the clinical translation of precision diabetes medicine.
    Tobias DK; Merino J; Ahmad A; Aiken C; Benham JL; Bodhini D; Clark AL; Colclough K; Corcoy R; Cromer SJ; Duan D; Felton JL; Francis EC; Gillard P; Gingras V; Gaillard R; Haider E; Hughes A; Ikle JM; Jacobsen LM; Kahkoska AR; Kettunen JLT; Kreienkamp RJ; Lim LL; Männistö JME; Massey R; Mclennan NM; Miller RG; Morieri ML; Most J; Naylor RN; Ozkan B; Patel KA; Pilla SJ; Prystupa K; Raghavan S; Rooney MR; Schön M; Semnani-Azad Z; Sevilla-Gonzalez M; Svalastoga P; Takele WW; Tam CH; Thuesen ACB; Tosur M; Wallace AS; Wang CC; Wong JJ; Yamamoto JM; Young K; Amouyal C; Andersen MK; Bonham MP; Chen M; Cheng F; Chikowore T; Chivers SC; Clemmensen C; Dabelea D; Dawed AY; Deutsch AJ; Dickens LT; DiMeglio LA; Dudenhöffer-Pfeifer M; Evans-Molina C; Fernández-Balsells MM; Fitipaldi H; Fitzpatrick SL; Gitelman SE; Goodarzi MO; Grieger JA; Guasch-Ferré M; Habibi N; Hansen T; Huang C; Harris-Kawano A; Ismail HM; Hoag B; Johnson RK; Jones AG; Koivula RW; Leong A; Leung GKW; Libman IM; Liu K; Long SA; Lowe WL; Morton RW; Motala AA; Onengut-Gumuscu S; Pankow JS; Pathirana M; Pazmino S; Perez D; Petrie JR; Powe CE; Quinteros A; Jain R; Ray D; Ried-Larsen M; Saeed Z; Santhakumar V; Kanbour S; Sarkar S; Monaco GSF; Scholtens DM; Selvin E; Sheu WH; Speake C; Stanislawski MA; Steenackers N; Steck AK; Stefan N; Støy J; Taylor R; Tye SC; Ukke GG; Urazbayeva M; Van der Schueren B; Vatier C; Wentworth JM; Hannah W; White SL; Yu G; Zhang Y; Zhou SJ; Beltrand J; Polak M; Aukrust I; de Franco E; Flanagan SE; Maloney KA; McGovern A; Molnes J; Nakabuye M; Njølstad PR; Pomares-Millan H; Provenzano M; Saint-Martin C; Zhang C; Zhu Y; Auh S; de Souza R; Fawcett AJ; Gruber C; Mekonnen EG; Mixter E; Sherifali D; Eckel RH; Nolan JJ; Philipson LH; Brown RJ; Billings LK; Boyle K; Costacou T; Dennis JM; Florez JC; Gloyn AL; Gomez MF; Gottlieb PA; Greeley SAW; Griffin K; Hattersley AT; Hirsch IB; Hivert MF; Hood KK; Josefson JL; Kwak SH; Laffel LM; Lim SS; Loos RJF; Ma RCW; Mathieu C; Mathioudakis N; Meigs JB; Misra S; Mohan V; Murphy R; Oram R; Owen KR; Ozanne SE; Pearson ER; Perng W; Pollin TI; Pop-Busui R; Pratley RE; Redman LM; Redondo MJ; Reynolds RM; Semple RK; Sherr JL; Sims EK; Sweeting A; Tuomi T; Udler MS; Vesco KK; Vilsbøll T; Wagner R; Rich SS; Franks PW
    Nat Med; 2023 Oct; 29(10):2438-2457. PubMed ID: 37794253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Application of polygenic risk scores in risk prediction and precision prevention of complex diseases: opportunities and challenges].
    Hang D; Shen HB
    Zhonghua Liu Xing Bing Xue Za Zhi; 2019 Sep; 40(9):1027-1030. PubMed ID: 31594139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Personalized medicine in diabetes.
    Malandrino N; Smith RJ
    Clin Chem; 2011 Feb; 57(2):231-40. PubMed ID: 21127150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monogenic diabetes: Implementation of translational genomic research towards precision medicine.
    Vaxillaire M; Froguel P
    J Diabetes; 2016 Nov; 8(6):782-795. PubMed ID: 27390143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polygenic risk for coronary heart disease acts through atherosclerosis in type 2 diabetes.
    Lu T; Forgetta V; Yu OHY; Mokry L; Gregory M; Thanassoulis G; Greenwood CMT; Richards JB
    Cardiovasc Diabetol; 2020 Jan; 19(1):12. PubMed ID: 32000781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Precision medicine for monogenic diabetes: from a survey to the development of a next-generation diagnostic panel.
    Kherra S; Blouin JL; Santoni F; Schwitzgebel V
    Swiss Med Wkly; 2017; 147():w14535. PubMed ID: 29120028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Practicing precision medicine with intelligently integrative clinical and multi-omics data analysis.
    Ahmed Z
    Hum Genomics; 2020 Oct; 14(1):35. PubMed ID: 33008459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Future Roadmaps for Precision Medicine Applied to Diabetes: Rising to the Challenge of Heterogeneity.
    Bowman P; Flanagan SE; Hattersley AT
    J Diabetes Res; 2018; 2018():3061620. PubMed ID: 30599002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotypic and genetic classification of diabetes.
    Deutsch AJ; Ahlqvist E; Udler MS
    Diabetologia; 2022 Nov; 65(11):1758-1769. PubMed ID: 35953726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progress in defining the molecular basis of type 2 diabetes mellitus through susceptibility-gene identification.
    McCarthy MI
    Hum Mol Genet; 2004 Apr; 13 Spec No 1():R33-41. PubMed ID: 14722160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical utility of the polygenic LDL-C SNP score in familial hypercholesterolemia.
    Futema M; Bourbon M; Williams M; Humphries SE
    Atherosclerosis; 2018 Oct; 277():457-463. PubMed ID: 30270085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polygenic risk scores, prediction of psychiatric disorders, and the health of all of us.
    Parens E; Matthews L; Appelbaum PS
    Lancet Psychiatry; 2020 Jun; 7(6):481. PubMed ID: 32445683
    [No Abstract]   [Full Text] [Related]  

  • 20. Precision Diabetes Is Slowly Becoming a Reality.
    Mohan V; Radha V
    Med Princ Pract; 2019; 28(1):1-9. PubMed ID: 30685765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.